Economic information and modeling report
Modeling overview
1 evidence topic · 1 source
Summary
An abstract-only preprint describes an illustrative Spanish managed-access model for saroglitazar. Its prices and spending estimates are modeled, not observed commercial prices or payer expenditure. The full model was unavailable for appraisal.